Back
HFA Premium Access

Identification and characterization of small-molecule ERBB4 agonists as a treatment for heart failure

Session: New therapeutic approaches for heart failure
Topic: Heart Failure
Speaker: Miss E. Feyen (Antwerp, BE)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Miss Eline Feyen

University of Antwerp, Antwerp (Belgium)
0 follower

4 more presentations in this session

Repurposing of glatiramer acetate to treat cardiac ischemia

Speaker: Doctor G. Aviel (Rehovot, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

FXa promotes endothelial dysfunction and pro-remodeling responses in atrial endothelial cells involving PAR1 and 2 and AT1R/NADPH oxidase/SGLT1/2 pro-oxidant pathways

Speaker: Ms W. Fakih (Strasbourg, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.

Speaker: Ms A. Linders (Groningen, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Living myocardial slices for the study of nucleic acid-based therapies

Speaker: Doctor R. Nunez-Toldra (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

New therapeutic approaches for heart failure

Speakers: Miss E. Feyen, Doctor G. Aviel, Ms W. Fakih, Ms A. Linders, Doctor R. Nunez-Toldra
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources